Non-Small Cell Lung Cancer (NSCLC) Clinical Trial Options

Non-Small Cell Lung Cancer Treatments

If you have NSCLC, We can help you. Massive Bio’s advanced AI system will match and suggest a range of potential lung cancer treatments for your unique medical situation. Our Patient Relations Coordinators will evaluate your submission and reach out to you.

Understanding your options is crucial when facing a locally advanced or unresectable non-small cell lung cancer (NSCLC) diagnosis. Our cutting-edge clinical trial aims to explore new, targeted treatments designed specifically for patients like you – for free.

By signing up for our matching program, you’ll be connected to a network of clinical trials specifically tailored to your needs. Here’s how it works:

Diagnosis: If you have been diagnosed with Stage 3 non small cell lung cancer and it can’t be fully removed with surgery, you’re a potential candidate for these innovative clinical trials.

What is Non Small Cell Lung Cancer?: Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, accounting for approximately 80-85% of cases, distinguished by the size of the cancer cells which are larger than those of small cell lung cancer. It encompasses several subtypes, including adenocarcinoma, squamous cell carcinoma, and large cell carcinoma, each with its own patterns of growth and spread. NSCLC tends to progress at a slower pace than small cell lung cancer and is generally more responsive to surgical interventions, particularly when diagnosed at an early stage. Despite this, NSCLC remains a leading cause of cancer-related mortality globally, with outcomes and survival rates varying significantly based on the stage at diagnosis and the molecular characteristics of the tumor.

Recommended biomarkers:

ALK (+):ALK+ refers to cells that have a change or mutation in the ALK gene, which can lead to abnormal cell growth. This change is often seen in some cancers, like certain types of lung cancer, where it helps doctors decide on targeted treatments that can specifically attack the ALK+ cancer cells.

ROS1:ROS1 is a gene that can undergo genetic changes, or mutations, which sometimes lead to the development of cancer due to uncontrolled cell growth. In some lung cancers, identifying a ROS1 mutation is important because it can be targeted by specific drugs that can more effectively treat the cancer.

RET:RET is a gene that produces a protein involved in cell signaling pathways that influence cell growth and survival. When altered or mutated, the RET gene can contribute to the development of cancers, such as thyroid cancer and a subset of lung cancers, making it a target for specific therapies that can inhibit its abnormal activity.

How can I find my biomarker NGS Testing: NGS testing, or Next-Generation Sequencing, is a modern way to examine your DNA—the blueprint of your body—very closely and quickly. It reads the tiny parts of your DNA to find any changes that might cause the disease or affect how you respond to medications. Certain clinical trials require NGS testing to find out the origin of the cancer and target it directly.

Innovative Therapy: This clinical trial brings together the latest advancements in medical science and technology to target your lung cancer with precision and effectiveness.

Personalized Match: We understand that every patient is unique, and that’s why we focus on matching you with a clinical trial that aligns with your specific requirements and medical history, whether you’re dealing with non-small cell lung cancer or other forms of lung cancer.

Personalized Guidance: Throughout your journey, our experienced clinical team will be by your side, providing guidance, support, and answering any questions you may have about NSCLC treatment and NSCLC clinical research studies.

By signing up for our matching program, you’re taking an active role in exploring new possibilities and gaining access to an innovative therapy that can potentially transform your life.

Please note: To qualify for our treatments, it’s essential that you have undergone an NGS test showing an ALK+ or ROS1+ result; if you haven’t, we can arrange a free NGS test for individuals diagnosed with certain conditions, helping pave the way towards potential treatment options.